Catalyst Pharm Inc (CPRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,665 | -5,700 | -18,412 | -13,025 | -8,847 |
| Depreciation Amortization | 16 | 8 | 46 | 39 | 26 |
| Accounts payable and accrued liabilities | -1,023 | -1,141 | 1,012 | 148 | -241 |
| Other Working Capital | -702 | -1,361 | 2,029 | 1,164 | 162 |
| Other Operating Activity | 2,531 | 2,112 | 1,582 | 1,961 | 1,820 |
| Operating Cash Flow | $-10,843 | $-6,082 | $-13,743 | $-9,713 | $-7,080 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -36,791 | -31,848 | -4 | -65 | -35 |
| PPE Investments | -12 | N/A | N/A | N/A | N/A |
| Investing Cash Flow | $-36,803 | $-31,848 | $-4 | $-65 | $-35 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 42 | 33 | 57,350 | 3,213 | 1,805 |
| Other Financing Activity | -4 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $37 | $33 | $57,350 | $3,213 | $1,805 |
| Beginning Cash Position | 57,497 | 57,497 | 13,893 | 13,893 | 13,893 |
| End Cash Position | 9,888 | 19,601 | 57,497 | 7,329 | 8,584 |
| Net Cash Flow | $-47,609 | $-37,896 | $43,604 | $-6,564 | $-5,309 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,843 | -6,082 | -13,743 | -9,713 | -7,080 |
| Capital Expenditure | -12 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -10,855 | -6,082 | -13,743 | -9,713 | -7,080 |